2021
DOI: 10.3389/fphar.2020.624888
|View full text |Cite
|
Sign up to set email alerts
|

Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region

Abstract: Backround: We aimed at assessing the prevalence of polypharmacy and potential drug-drug interactions (DDIs) with clinical relevance in elderly patient on Emilia Romagna area. Both outpatients and residents in nursing homes were assessed, with only partially overlapping strategies.Methods: We defined a list of 190 pairs of potentially interacting drugs, based on literature appraisal and availability of therapeutic alternatives. January-June 2018 data on drug use in patients over 65 years-old were collected from… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 28 publications
4
18
0
Order By: Relevance
“…In good agreement with the findings of the international literature [ 20 , 21 , 22 , 23 , 24 ], women showed higher STOPP alerts and lower START alerts.…”
Section: Discussionsupporting
confidence: 91%
“…In good agreement with the findings of the international literature [ 20 , 21 , 22 , 23 , 24 ], women showed higher STOPP alerts and lower START alerts.…”
Section: Discussionsupporting
confidence: 91%
“…6,7 The reasons for this higher burden in the elderly are multiple and involve higher exposure to polymedication, changes in pharmacokinetics and/ or pharmacodynamics, and a care trajectory involving a higher number of health professionals. 8,9 In this population, the prevalence of dispensing for drugs whose concomitant use is contraindicated was estimated to be 0.4%, and 2.3% for drugs whose concomitant use is discommended. 10 As not all concomitant use of drugs known to interact leads to situations of clinically meaningful DDIs and, potentially, to adverse reactions, prevalence/incidence studies of such at-risk coprescribing or codispensing cannot preclude the concrete clinical impact of DDIs.…”
Section: Introductionmentioning
confidence: 98%
“…DDIs are estimated to be responsible for about 1% of hospital admissions in the general population 4,5 and 2 to 5% of hospital admissions in elderly patients 6,7 . The reasons for this higher burden in the elderly are multiple and involve higher exposure to polymedication, changes in pharmacokinetics and/or pharmacodynamics, and a care trajectory involving a higher number of health professionals 8,9 . In this population, the prevalence of dispensing for drugs whose concomitant use is contraindicated was estimated to be 0.4%, and 2.3% for drugs whose concomitant use is discommended 10 …”
Section: Introductionmentioning
confidence: 99%
“…Approximately threequarters of residents used five or more prescription medicines regularly, and almost one-quarter used more than nine, according to a recent survey of NHs in eight European countries 5 . Many of these regimens include superfluous or redundant medicines, which are equally as likely as recommended pharmaceuticals to cause undesirable side effects and interact with one another 14 . This was recently discovered through extensive study in the United States' NHs.…”
Section: Introductionmentioning
confidence: 99%